Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica

被引：21

作者：

Belet, N

Çiftçi, E

Ince, E

Dalgiç, N

Öncel, S

Güriz, H

Yagmurlu, A

Dindar, H

Dogru, U

机构：

[1] Ankara Univ, Sch Med, Dept Paediat, Infect Dis Sect, Ankara, Turkey

[2] Sect Paediat Surg, Dept Microbiol, Ankara, Turkey

[3] Sect Paediat Surg, Dept Surg, Ankara, Turkey

来源：

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2006年 / 38卷 / 6-7期

关键词：

LIPOSOMAL AMPHOTERICIN-B; PEDIATRIC-PATIENTS; THERAPY;

D O I：

10.1080/00365540500404052

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Candida lipolytica has infrequently been identified as a cause of infection and is associated mostly with vascular catheter-related fungaemia. Patients reported in the literature have been successfully treated with catheter removal or amphotericin B treatment. We report 2 infants with C. lipolytica fungaemia unresponsive to catheter removal and amphotericin B therapy and treated successfully with the addition of caspofungin to amphotericin B.

引用

收藏

页码：559 / 562

页数：4

相关论文

共 10 条

[1] Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant [J].

Castagnola, E ;

Machetti, M ;

Cappelli, B ;

Molinari, AC ;

Morreale, G ;

Dodero, P ;

Toma, P ;

Faraci, M .

CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (03) :255-257

[2] Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation [J].

D'Antonio, D ;

Romano, F ;

Pontieri, EE ;

Fioritoni, G ;

Caracciolo, C ;

Bianchini, S ;

Olioso, P ;

Staniscia, T ;

Sferra, R ;

Boccia, S ;

Vetuschi, A ;

Federico, G ;

Gaudio, E ;

Carruba, G .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1381-1386

[3] Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis [J].

Elanjikal, Z ;

Sörensen, J ;

Schmidt, H ;

Dupuis, W ;

Tintelnot, K ;

Jautzke, G ;

Klingebiel, T ;

Lehrnbecher, T .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (07) :653-656

[4] Retrospective study of the safety of caspofungin in immunocompromised pediatric patients [J].

Franklin, JA ;

McCormick, J ;

Flynn, PM .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (08) :747-749

[5]

Kullberg BJ, 2002, EUR J MED RES, V7, P183

[6] Nosocomial cluster of Candida lipolytica fungemia in pediatric patients [J].

Shin, JH ;

Kook, H ;

Shin, DH ;

Hwang, TJ ;

Kim, M ;

Suh, SP ;

Ryang, DW .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (05) :344-349

[7] Echinocandins - An advance in the primary treatment of invasive candidiasis. [J].

Walsh, TJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2070-2072

[8] Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia [J].

Walsh, TJ ;

Teppler, H ;

Donowitz, GR ;

Maertens, JA ;

Baden, LR ;

Dmoszynska, A ;

Cornely, OA ;

Bourque, MR ;

Lupinacci, RJ ;

Sable, CA ;

dePauw, BE .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) :1391-1402

[9] CLINICAL, MICROBIOLOGICAL, AND EXPERIMENTAL ANIMAL STUDIES OF CANDIDA-LIPOLYTICA [J].

WALSH, TJ ;

SALKIN, IF ;

DIXON, DM ;

HURD, NJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (05) :927-931

[10]

Wertz Karin K, 2004, Pediatr Crit Care Med, V5, P181, DOI 10.1097/01.PCC.0000113264.00053.AF